Suchergebnisse - "Crawford, David E"

PubPharm (8)

1

Optimizing outcomes in men with prostate cancer : the cardiovascular event lowering (CaELo) pathways

enthalten in: The Canadian journal of urology | 2024

von Crawford, D. | Albala, D. | Garnick, M. | +9

2

Role of Genetic Testing for Inherited Prostate Cancer Risk : Philadelphia Prostate Cancer Consensus Conference 2017

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Giri, V. | Knudsen, K. | Kelly, W. | +67

CommentIn: Eur Urol. 2018 Sep;74(3):397. - PMID 29656853

3

A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer : Southwest Oncology Group Study S0312

enthalten in: American journal of clinical oncology | 2009

von Van Veldhuizen, P. | Hussey, M. | Lara, P. | +5

4

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

enthalten in: European urology | 2009

von Malmström, P. | Sylvester, R. | Crawford, D. | +6

CommentIn: Eur Urol. 2009 Aug;56(2):257-8; discussion 258-9. - PMID 19427109

5

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

enthalten in: European urology | 2009

von Malmström, P. | Sylvester, R. | Crawford, D. | +6

6

Genetic variation in the HSD17B1 gene and risk of prostate cancer

enthalten in: PLoS genetics | 2005

von Kraft, P. | Pharoah, P. | Chanock, S. | +43

7

Clinical trials and protocols update

enthalten in: Urologic oncology | 2001

von Crawford, D. | Lerner, S.

8

Phase II Trial of Mitotane and Cisplatin in Patients With Adrenal Carcinoma: A Southwest Oncology Group Study

enthalten in: Journal of clinical oncology / Englische Ausgabe | 1993

von Bukowski, R. | Wolfe, M. | Levine, H. | +4

1
[1]